Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
Archives of Pathology & Laboratory Medicine
|
December 8, 2024
Can Morphology and Immune Infiltration Predict the Homologous Recombination Deficiency Status in Newly Diagnosed High-Grade Serous Ovarian Carcinoma?
Amel Kime, Guillaume Bataillon, Isabelle Treilleux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 16, 2025
Unravelling the tumor microenvironment and PD-L1 expression across tissue type in high-grade serous ovarian cancer in the NeoPembrOV/GINECO phase II randomized trial
Laetitia Collet, Maude Ardin, David Venet, et al.
Nature Communications
|
December 1, 2020
Lkb1 suppresses amino acid-driven gluconeogenesis in the liver
Pierre-Alexandre Just, Sara Charawi, Raphaël G P Denis, et al.
Nature Communications
|
March 18, 2021
Author Correction: Lkb1 suppresses amino acid-driven gluconeogenesis in the liver
Pierre-Alexandre Just, Sara Charawi, Raphaël G P Denis, et al.
JCO Oncology Practice
|
November 24, 2025
Predictors of Successful Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery in Management of Ovarian Cancer
Claudia Marchetti, Gwenael Ferron, Olivier Colomban, et al.
Gynecologic Oncology
|
February 6, 2022
A phase II study of Navitoclax (ABT-263) as single agent in women heavily pretreated for recurrent epithelial ovarian cancer: The MONAVI - GINECO study
Florence Joly, Michel Fabbro, Philippe Follana, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 12, 2024
Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer
Romain Boidot, Michael G B Blum, Marie-Pierre Wissler, et al.
Gynecologic Oncology
|
January 16, 2022
Development and validation of a RNAseq signature for prognostic stratification in endometrial cancer
Guillaume Beinse, Marie-Aude Le Frere Belda, Pierre-Alexandre Just, et al.
JCO Precision Oncology
|
January 14, 2026
Early Clinical and Molecular Biomarkers in Patients With Advanced Ovarian Cancer Undergoing Neoadjuvant Chemotherapy: CHIVA Phase II GINECO Trial
Félix Blanc-Durand, Benoit You, Yahia Adnani, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 19, 2025
Association between molecular classification and overall survival in patients with metastatic endometrial carcinoma: ancillary results of the UTOLA phase II GINECO trial
Guillaume Beinse, Karen Leroy, Pierre-Alexandre Just, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
Archives of Pathology & Laboratory Medicine
|
December 8, 2024
Can Morphology and Immune Infiltration Predict the Homologous Recombination Deficiency Status in Newly Diagnosed High-Grade Serous Ovarian Carcinoma?
Amel Kime, Guillaume Bataillon, Isabelle Treilleux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 16, 2025
Unravelling the tumor microenvironment and PD-L1 expression across tissue type in high-grade serous ovarian cancer in the NeoPembrOV/GINECO phase II randomized trial
Laetitia Collet, Maude Ardin, David Venet, et al.
Nature Communications
|
December 1, 2020
Lkb1 suppresses amino acid-driven gluconeogenesis in the liver
Pierre-Alexandre Just, Sara Charawi, Raphaël G P Denis, et al.
Nature Communications
|
March 18, 2021
Author Correction: Lkb1 suppresses amino acid-driven gluconeogenesis in the liver
Pierre-Alexandre Just, Sara Charawi, Raphaël G P Denis, et al.
JCO Oncology Practice
|
November 24, 2025
Predictors of Successful Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery in Management of Ovarian Cancer
Claudia Marchetti, Gwenael Ferron, Olivier Colomban, et al.
Gynecologic Oncology
|
February 6, 2022
A phase II study of Navitoclax (ABT-263) as single agent in women heavily pretreated for recurrent epithelial ovarian cancer: The MONAVI - GINECO study
Florence Joly, Michel Fabbro, Philippe Follana, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 12, 2024
Clinical evaluation of a low-coverage whole-genome test for detecting homologous recombination deficiency in ovarian cancer
Romain Boidot, Michael G B Blum, Marie-Pierre Wissler, et al.
Gynecologic Oncology
|
January 16, 2022
Development and validation of a RNAseq signature for prognostic stratification in endometrial cancer
Guillaume Beinse, Marie-Aude Le Frere Belda, Pierre-Alexandre Just, et al.
JCO Precision Oncology
|
January 14, 2026
Early Clinical and Molecular Biomarkers in Patients With Advanced Ovarian Cancer Undergoing Neoadjuvant Chemotherapy: CHIVA Phase II GINECO Trial
Félix Blanc-Durand, Benoit You, Yahia Adnani, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 19, 2025
Association between molecular classification and overall survival in patients with metastatic endometrial carcinoma: ancillary results of the UTOLA phase II GINECO trial
Guillaume Beinse, Karen Leroy, Pierre-Alexandre Just, et al.
Page
of 8